The Cambridge Centre for Myelin Repair (CCMR) is a UK research initiative funded by the MS Society, with a clear mission: to accelerate the development of effective treatments for progressive multiple sclerosis, where there are currently no therapies to halt disability progression. CCMR brings together leading scientists and clinicians at the University of Cambridge, working at the interface of fundamental neuroscience and clinical translation t…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.